PHASE-I CLINICAL-EVALUATION OF HUMAN-PLASMA FIBRONECTIN (FN) IN TRAUMA PATIENTS

被引：0
|
作者：
HOROWITZ, MS
HOROWITZ, B
MAY, JR
TREAT, RC
HALL, EL
DIPIRO, JT
DORAN, JE
MANSBERGER, AR
机构：
[1] MED COLL GEORGIA,AUGUSTA,GA 30912
[2] NEW YORK BLOOD CTR,NEW YORK,NY 10021
来源：
THROMBOSIS AND HAEMOSTASIS | 1985年 / 54卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [21] PHASE-I EVALUATION OF PIPERAZINEDIONE IN PATIENTS WITH ADVANCED CANCER
    CURRIE, V
    WOODCOCK, T
    TAN, C
    KRAKOFF, I
    YOUNG, C
    CANCER TREATMENT REPORTS, 1979, 63 (01): : 73 - 76
  • [22] SELECTIVE BINDING-AFFINITY OF HUMAN-PLASMA FIBRONECTIN FOR THE COLLAGENS I-IV
    WORTHEN, DM
    CLEVELAND, PH
    SLIGHT, JR
    ABARE, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1985, 26 (12) : 1740 - 1744
  • [23] PHASE-I AND PHARMACOLOGIC EVALUATION OF NAFAZATROM IN PATIENTS WITH CANCER
    HAAS, CD
    BAKER, LH
    EVANS, LJ
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 13 - 17
  • [24] REVERSAL OF OPSONIC DEFICIENCY IN SURGICAL, TRAUMA, AND BURN PATIENTS BY INFUSION OF PURIFIED HUMAN-PLASMA FIBRONECTIN - CORRELATION WITH EXPERIMENTAL-OBSERVATIONS
    SABA, TM
    BLUMENSTOCK, FA
    SHAH, DM
    LANDABURU, RH
    HRINDA, ME
    DENO, DC
    HOLMAN, JM
    CHO, E
    DAYTON, C
    CARDARELLI, PM
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (02): : 229 - 240
  • [25] CLINICAL-EVALUATION OF A 2-SITE IMMUNORADIOMETRIC ASSAY FOR ADRENOCORTICOTROPIN IN UNEXTRACTED HUMAN-PLASMA USING MONOCLONAL-ANTIBODIES
    WHITE, A
    SMITH, H
    HOADLEY, M
    DOBSON, SH
    RATCLIFFE, JG
    CLINICAL ENDOCRINOLOGY, 1987, 26 (01) : 41 - 52
  • [26] CLINICAL-EVALUATION OF PLASMA CRYOPRECIPITATE VS CRYOPRECIPITATE EXTRACTED PLASMA ON OPSONIC ACTIVITY AND PLASMA FIBRONECTIN IN SEPTIC AND NON-SEPTIC INJURED PATIENTS
    SABA, TM
    BLUMENSTOCK, FA
    STRATTON, H
    SHAH, D
    CHO, E
    NEWELL, J
    RAHM, R
    CIRCULATORY SHOCK, 1982, 9 (02) : 207 - 207
  • [27] PHASE-I AND CLINICAL PHARMACOLOGICAL EVALUATION OF A PARENTERAL HEXAMETHYLMELAMINE FORMULATION
    AMES, MM
    RICHARDSON, RL
    KOVACH, JS
    MOERTEL, CG
    OCONNELL, MJ
    CANCER RESEARCH, 1990, 50 (01) : 206 - 210
  • [28] PHASE-I AND CLINICAL PHARMACOLOGICAL EVALUATION OF PIROZANTRONE HYDROCHLORIDE (OXANTRAZOLE)
    AMES, MM
    LOPRINZI, CL
    COLLINS, JM
    VANHAELSTPISANI, C
    RICHARDSON, RL
    RUBIN, J
    MOERTEL, CG
    CANCER RESEARCH, 1990, 50 (13) : 3905 - 3909
  • [29] PHASE-I STUDY OF INTRAPERITONEAL MITOXANTRONE CLINICAL AND PHARMACOKINETIC EVALUATION
    BLOCHLDAUM, B
    EICHLER, HG
    RAINER, H
    JAKESZ, R
    SALZER, H
    STEGER, G
    SCHULLER, J
    GUNTHER, E
    PROKSCH, P
    EHNINGER, G
    ONKOLOGIE, 1987, 10 (01): : 54 - 56
  • [30] PRELIMINARY EVALUATION OF A PHASE-I CLINICAL-STUDY OF QUELAMYCIN
    CORTES, H
    VICENTE, J
    BAENA, L
    OTERO, J
    GOSALVEZ, M
    EUROPEAN JOURNAL OF CANCER, 1978, 14 (12) : 1359 - 1361
12345